Do anti‐CD36 antibodies cause only fetal/neonatal alloimmune thrombocytopenia?

British Journal of HaematologyEarly View LETTER TO THE EDITOR Do anti-CD36 antibodies cause only foetal/neonatal alloimmune thrombocytopenia? Quan-Rui Liu, Quan-Rui Liu orcid.org/0009-0006-7953-1016 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorJing-Yu Liu, Jing-Yu Liu Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorJing-Ya Zhao, Jing-Ya Zhao Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorShao-Bin Lin, Shao-Bin Lin Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorJing Deng, Jing Deng Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, ChinaSearch for more papers by this authorXiu-Zhang Xu, Corresponding Author Xiu-Zhang Xu [email protected] Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, China Correspondence Yi Zhou, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Email: [email protected] Xiu-Zhang Xu, Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, China. Email: [email protected]Search for more papers by this authorYi Zhou, Corresponding Author Yi Zhou [email protected] Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China Correspondence Yi Zhou, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Email: [email protected] Xiu-Zhang Xu, Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, China. Email: [email protected]Search for more papers by this author Quan-Rui Liu, Quan-Rui Liu orcid.org/0009-0006-7953-1016 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorJing-Yu Liu, Jing-Yu Liu Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorJing-Ya Zhao, Jing-Ya Zhao Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorShao-Bin Lin, Shao-Bin Lin Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, ChinaSearch for more papers by this authorJing Deng, Jing Deng Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, ChinaSearch for more papers by this authorXiu-Zhang Xu, Corresponding Author Xiu-Zhang Xu [email protected] Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, China Correspondence Yi Zhou, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Email: [email protected] Xiu-Zhang Xu, Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, China. Email: [email protected]Search for more papers by this authorYi Zhou, Corresponding Author Yi Zhou [email protected] Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China Correspondence Yi Zhou, Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Email: [email protected] Xiu-Zhang Xu, Institute of Blood Transfusion, Guangzhou Blood Centre, Guangzhou, Guangdong, China. Email: [email protected]Search for more papers by this author First published: 16 July 2023 https://doi.org/10.1111/bjh.18969 Quan-Rui Liu and Jing-Yu Liu contributed equally to this study and should be considered as cofirst authors. Yi Zhou and Xiu-Zhang Xu contributed equally to this work and should be considered as cocorresponding authors. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES 1Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al. 348 Cases of suspected neonatal alloimmune thrombocytopenia. Lancet. 1989; 1(8634): 363– 66. 2Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013; 161(1): 3– 14. 3Ohto H, Miura S, Ariga H, Ishii T, Fujimori K, Morita S, et al. The natural history of maternal immunization against foetal platelet alloantigens. Transfus Med. 2004; 14(6): 399– 408. 4Xia W, Ye X, Xu X, Ding H, Liu J, Deng J, et al. Two cases of platelet transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China. Transfus Med. 2014; 24(4): 254– 56. 5Wu G, Zhou Y, Li L, Zhong Z, Li H, Li H, et al. Platelet immunology in China: research and clinical applications. Transfus Med Rev. 2017; 31(2): 118– 25. 6Xu X, Li L, Xia W, Ding H, Chen D, Liu J, et al. Successful management of a hydropic fetus with severe anemia and thrombocytopenia caused by anti-CD36 antibody. Int J Hematol. 2018; 107(2): 251– 56. 7Wu Y, Chen D, Xu X, Mai M, Ye X, Li C, et al. Hydrops fetalis associated with anti-CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: possible underlying mechanism. Transfus Med. 2020; 30(5): 361– 68. 8Okajima S, Cho K, Chiba H, Azuma H, Mochizuki T, Yamaguchi M, et al. Two sibling cases of hydrops fetalis due to alloimmune anti-CD36 (Nak a) antibody. Thromb Haemost. 2006; 95(2): 267– 71. 9Xu X, Ye X, Xia W, Liu J, Ding H, Deng J, et al. Studies on CD36 deficiency in South China: two cases demonstrating the clinical impact of anti-CD36 antibodies. Thromb Haemost. 2013; 110(6): 1199– 206. 10Yamamoto N, Akamatsu N, Sakuraba H, Yamazaki H, Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood. 1994; 83: 392– 97. 11Mao B, Huang S, Lu X, Sun W, Zhou Y, Pan X, et al. Early development of definitive erythroblasts from human pluripotent stem cells defined by expression of glycophorin A/CD235a, CD34, and CD36. Stem Cell Reports. 2016; 7(5): 869– 83. 12Deitch EA, Condon M, Feketeova E, Machiedo GW, Mason L, Vinluan GM, et al. Trauma-hemorrhagic shock induces a CD36-dependent RBC endothelial-adhesive phenotype. Crit Care Med. 2014; 42(3): e200– 10. 13Xu X, Chen D, Ye X, Xia W, Xu Y, Chen Y, et al. Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model. Blood. 2021; 138(18): 1757– 67. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation